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Background
Endemic Burkitt’s lymphoma, the most prevalent child-
hood cancer in Equatorial Africa, is a rapidly growing
B-cell malignancy that is ultimately fatal if untreated.
Two co-factors are linked to the etiology of this pedia-
tric cancer: Epstein-Barr virus (EBV) infection, and sus-
tained and intense exposure to Plasmodium falciparum
malaria (holoendemic malaria). In this study, we wanted
to test the hypothesis that P. falciparum infections dur-
ing early infancy results in elevated EBV viral load
which results in diminished EBV-specific T-cell immune
responses over time.
Methods
Infants were enrolled from two rural sites in Kenya:
Kisumu District where malaria transmission is holoen-
demic and risk for eBL is high and Nandi District where
malaria transmission is limited and the risk for eBL is low.
Finger prick blood samples were taken through 2 years of
age to measure EBV viral load, EBV antibodies, and
malaria parasitemia. Venous blood samples were collected
at 12, 18 and 24 months of age and PBMC were isolated
and stimulated with peptides for both EBV lytic and latent
antigens. After 2.5 days of stimulation, IFNg ELISPOTS
enumerated EBV-specific T cell responses, and the num-
ber of SFU/10
6 PBMC was determined by scanning with
ImmunoSpot Reader and Software.
Results
When we compared EBV lytic and latent IFNg Tc e l l
responses at 12, 18 and 24 months of age, we saw that
although children in Kisumu were able to mount an IFNg
response against EBV lytic peptides, the magnitude of
that response declined significantly by 24 months of age.
In contrast, the magnitude of the response did not
decline in the Nandi cohort. We also observed higher
overall viral loads in infants from Kisumu suggesting that
the apparent loss of EBV-specific IFNg response to lytic
antigens in the Kisumu children may be associated with
these higher viral loads.
Conclusions
We found that by 2 years of age, there was a significant
difference in the capacity of children living in a malaria
holoendemic region compared to malaria sporadic region
to maintain a T cell response to EBV lytic antigens. This
suggests that P. falciparum malaria contributes to loss of
EBV-specific immunity by inducing the collapse of an
antiviral IFN-g mediated CD8+ T cell response.
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